Anesthesia: Essays and Researches  Login  | Users Online: 664 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Home | About us | Editorial board | Ahead of print | Search | Current Issue | Archives | Submit article | Instructions | Copyright form | Subscribe | Advertise | Contacts


 
Table of Contents  
LETTER TO EDITOR
Year : 2016  |  Volume : 10  |  Issue : 3  |  Page : 686-687  

Thrombophlebitis of pinna a rare condition: Role of heparin spray


Department of Anaesthesiology and Critical Care Medicine, BHU Trauma Center, Varanasi, Uttar Pradesh, India

Date of Web Publication27-Sep-2016

Correspondence Address:
Neeraj Kumar
Sushruta Hostel, Room No. 173, BHU Trauma Center, Varanasi, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0259-1162.191123

Rights and Permissions

How to cite this article:
Kumar N, Kumar P, Singh Y, Mathur S K. Thrombophlebitis of pinna a rare condition: Role of heparin spray. Anesth Essays Res 2016;10:686-7

How to cite this URL:
Kumar N, Kumar P, Singh Y, Mathur S K. Thrombophlebitis of pinna a rare condition: Role of heparin spray. Anesth Essays Res [serial online] 2016 [cited 2020 Oct 1];10:686-7. Available from: http://www.aeronline.org/text.asp?2016/10/3/686/191123



Sir,

Thrombophlebitis of pinna is extremely rare in Intensive Care Unit (ICU). Thrombophlebitis is due to inflammation and thrombosis of vein, due to injury of wall of vein, prolonged immobility, infection, and due to various clotting disorder and malignancy.[1] Sign and symptoms are swelling, redness, pain, and tenderness of affected area. Diagnosis is usually clinical, but sometimes Doppler ultrasound required for confirmation. In general, treatment consists of support stockings and wraps, elevate the affected area to reduce swelling, keep pressure off of area to reduce pain, analgesics, anticoagulant and thrombolytic. Rarely, surgical removal or stripping of the vein is needed.

We are reporting a case of 15-year-old male patient admitted in trauma ICU with diagnosis of right temporoparietal contusion on noncontrast computed tomography scan, following a road traffic accident. The patient managed according to ICU protocol for head injury and started to improve. On the 5th day of ICU admission during routine care of the patient, staff nurse noticed that the right pinna was swollen, dark red, and tender on palpation [Figure 1]a. This thrombophlebitis of the right pinna may be due to prolonged pressure following immobilization or due to underlying bone fracture/scalp swelling over right temporal area. The rich network of veins in the temporal bone is in direct communication with extracranial veins which can lead to spread of underlying inflammation or infection to external ear. We manage this case by ensuring proper positioning and use of topical anticoagulant. As an anticoagulant, we used topical heparin preparation (Phlebotroy QPS, Troikaa Pharmaceutical Ltd.) containing 1000 IU/ml of heparin unlike other conventional gel or ointment containing only 200 IU/ml of heparin, 6–8 drops over affected area three times a day. After 3 days of local application, inflammation was resolved, and the color returned to normal [Figure 1]b.
Figure 1: (a) Thrombophlebitis over the right pinna. (b) Resolving thrombophlebitis after topical heparin application

Click here to view


On reviewing the literature, it was observed that thrombophlebitis of extremities is very common but rare of pinna in ICU setting. There are various predisposing factors such as vessel wall trauma, multiple irritant drugs infusions, pressure on dependent part, and alteration in blood clotting time in ICU setting. In our case, thrombophlebitis was mainly due to prolonged pressure on the right pinna. Heparin is a naturally occurring anticoagulant, used to reduce extension of inflammation and recurrence of thrombotic events. American College of Chest Physicians guidelines recommends topical heparin for the transfusion-related thrombophlebitis.[2] Poor penetration of drug through the skin limits the efficacy of currently available heparin formulations in the management of inflammation involving skin structures. We successfully used topical anticoagulant containing 1000 IU/ml of heparin with good skin penetration technology without any unwanted side effect.[3] With the experience of managing this case, it can be suggested that topical anticoagulant containing 1000 IU/ml of heparin ensures greater efficacy along with safety compared to conventional gels/ointments of topical heparin.

Acknowledgment

Written informed consent for publication obtained from the parents.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Nasr H, Scriven JM. Superficial thrombophlebitis (superficial venous thrombosis). BMJ 2015;350:h2039.  Back to cited text no. 1
    
2.
Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008;133 6 Suppl: 454S-545S.  Back to cited text no. 2
    
3.
Supe A, Subnis BM, Rao MR, Panchal VH, Lakhani RJ, Mehtalia B, et al. Novel topical quick penetrating solution of heparin in management of superficial thrombophlebitis: Results of randomized active controlled TRIAL. Int J Pharm Sci Res 2013;46:4442-6.  Back to cited text no. 3
    


    Figures

  [Figure 1]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References
    Article Figures

 Article Access Statistics
    Viewed1893    
    Printed3    
    Emailed0    
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal